Charles Schwab Investment Management Inc Shattuck Labs, Inc. Transaction History
Charles Schwab Investment Management Inc
- $601 Billion
- Q3 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 20,881 shares of STTK stock, worth $40,926. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,881
Previous 20,906
0.12%
Holding current value
$40,926
Previous $16,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding STTK
# of Institutions
60Shares Held
38.6MCall Options Held
22.2KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA6.31MShares$12.4 Million0.5% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.31MShares$12.4 Million0.02% of portfolio
-
Redmile Group, LLC San Francisco, CA5.54MShares$10.9 Million1.42% of portfolio
-
Prosight Management, LP Dallas, TX5.45MShares$10.7 Million3.36% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$4.85 Million0.0% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $83.1M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...